EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Stromal-induced epithelial-mesenchymal transition induces targetable drug resistance in acute lymphoblastic leukemia

Chun Shik Park, Hiroki Yoshihara, Qingsong Gao, Chunxu Qu, Ilaria Iacobucci, Pankaj S Ghate, Jon P Connelly, Shondra M Pruett-Miller, Ben Wagner, Camenzind G Robinson, Ashutosh Mishra, Junmin Peng und 9 weitere

Cell Reports · 2023-07 · 42 (7) · 112804

DOI: 10.1016/j.celrep.2023.112804 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2023-07. Verfasst von Chun Shik Park und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Precursor Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Alex's Lemonade Stand Foundation for Childhood Cancer, St. Jude Children's Research Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The bone marrow microenvironment (BME) drives drug resistance in acute lymphoblastic leukemia (ALL) through leukemic cell interactions with bone marrow (BM) niches, but the underlying mechanisms remain unclear. Here, we show that the interaction between ALL and mesenchymal stem cells (MSCs) through integrin β1 induces an epithelial-mesenchymal transition (EMT)-like program in MSC-adherent ALL cells, resulting in drug resistance and enhanced survival. Moreover, single-cell RNA sequencing analysis of ALL-MSC co-culture identifies a hybrid cluster of MSC-adherent ALL cells expressing both B-ALL and MSC signature genes, orchestrated by a WNT/β-catenin-mediated EMT-like program. Blockade of interaction between β-catenin and CREB binding protein impairs the survival and drug resistance of MSC-adherent ALL cells in vitro and results in a reduction in leukemic burden in vivo. Targeting of this WNT/β-catenin-mediated EMT-like program is a potential therapeutic approach to overcome cell extrinsically acquired drug resistance in ALL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial-Mesenchymal TransitionPrecursor Cell Lymphoblastic Leukemia-LymphomaHumansbeta CateninCoculture TechniquesDrug ResistanceCell ProliferationTumor Microenvironment

Stichwörter der Autor:innen

ALLCP: CancerWNTacute lymphoblastic leukemiabone marrow microenvironmentcell adhesioncell-cell interactionchemoresistancedrug resistanceepithelial-mesenchymal transitionmesenchymal stem cell

Substanzen

beta Catenin

Autor:innen und Institutionen

  • Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • Center for Advanced Genome Engineering, St. Jude Children's Research Hospital, Memphis, TN 38105, USA; Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • Cell and Tissue Imaging Center, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • Center for Proteomics and Metabolomics, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • Center for Proteomics and Metabolomics, St. Jude Children's Research Hospital, Memphis, TN 38105, USA; Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA; Department of Devel…
  • Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.

Förderung

  • NCI NIH HHS
  • Alex's Lemonade Stand Foundation for Childhood Cancer
  • St. Jude Children's Research Hospital
  • National Cancer Institute
  • National Institutes of Health

Zitieren

APA

Park, C. S., Yoshihara, H., Gao, Q., Qu, C., Iacobucci, I., Ghate, P. S., Connelly, J. P., Pruett-Miller, S. M., Wagner, B., Robinson, C. G., Mishra, A., Peng, J., Yang, L., Rankovic, Z., Finkelstein, D., Luger, S., Litzow, M., Paietta, E. M., Hebbar, N., …, & Mullighan, C. G. (2023). Stromal-induced epithelial-mesenchymal transition induces targetable drug resistance in acute lymphoblastic leukemia. Cell Reports, 42(7), 112804. https://doi.org/10.1016/j.celrep.2023.112804

Vancouver

Park CS, Yoshihara H, Gao Q, Qu C, Iacobucci I, Ghate PS, et al. Stromal-induced epithelial-mesenchymal transition induces targetable drug resistance in acute lymphoblastic leukemia. Cell Reports. 2023;42(7):112804. doi:10.1016/j.celrep.2023.112804

BibTeX
@article{Park2023,
  author = {Park, Chun Shik and Yoshihara, Hiroki and Gao, Qingsong and Qu, Chunxu and Iacobucci, Ilaria and Ghate, Pankaj S and Connelly, Jon P and Pruett-Miller, Shondra M and Wagner, Ben and Robinson, Camenzind G and Mishra, Ashutosh and Peng, Junmin and Yang, Lei and Rankovic, Zoran and Finkelstein, David and Luger, Selina and Litzow, Mark and Paietta, Elisabeth M and Hebbar, Nikhil and Velasquez, M Paulina and Mullighan, Charles G},
  title = {Stromal-induced epithelial-mesenchymal transition induces targetable drug resistance in acute lymphoblastic leukemia},
  journal = {Cell Reports},
  year = {2023},
  volume = {42},
  number = {7},
  pages = {112804},
  doi = {10.1016/j.celrep.2023.112804}
}
Kostenlos starten →